|
ALKS
|
Alkermes plc
|
0.08%
|
US
|
NASDAQ
|
|
DVA
|
DaVita HealthCare Partners Inc.
|
0.08%
|
US
|
NYSE
|
|
AMN
|
AMN Healthcare Services Inc
|
0.08%
|
US
|
NYSE
|
|
PINC
|
Premier, Inc.
|
0.07%
|
US
|
NASDAQ
|
|
OPCH
|
Option Care Health, Inc.
|
0.07%
|
US
|
NASDAQ
|
|
MMSI
|
Merit Medical Systems, Inc.
|
0.07%
|
US
|
NASDAQ
|
|
ITCI
|
Intra-Cellular Therapies Inc.
|
0.07%
|
US
|
NASDAQ
|
|
CYTK
|
Cytokinetics, Incorporated
|
0.07%
|
US
|
NASDAQ
|
|
APLS
|
Apellis Pharmaceuticals, Inc.
|
0.07%
|
US
|
NASDAQ
|
|
TDOC
|
Teladoc, Inc.
|
0.06%
|
US
|
NYSE
|
|
SYNH
|
Syneos Health, Inc.
|
0.06%
|
US
|
NASDAQ
|
|
NTRA
|
Natera, Inc.
|
0.06%
|
US
|
NASDAQ
|
|
NEOG
|
Neogen Corporation
|
0.06%
|
US
|
NASDAQ
|
|
MDGL
|
Madrigal Pharmaceuticals, Inc.
|
0.06%
|
US
|
NASDAQ
|
|
LNTH
|
Lantheus Holdings, Inc.
|
0.06%
|
US
|
NASDAQ
|
|
ICUI
|
ICU Medical, Inc.
|
0.06%
|
US
|
NASDAQ
|
|
CRSP
|
CRISPR Therapeutics AG
|
0.06%
|
US
|
NASDAQ
|
|
ARWR
|
Arrowhead Research Corporation
|
0.06%
|
US
|
NASDAQ
|
|
PBH
|
Prestige Brand Holdings, Inc.
|
0.06%
|
US
|
NYSE
|
|
HAE
|
Haemonetics Corporation
|
0.06%
|
US
|
NYSE
|